Cellectis (CLLS) has released its monthly share capital and voting rights report as of May 31, 2025. The company reported a total of 100,325,229 shares in its capital structure, with 89,110,384 total voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority. The company maintains its listing on Euronext Growth under the ISIN code FR0010425595.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – CLLS
-2.08%
-2.08%News Effect
On the day this news was published, CLLS declined 2.08%, reflecting a moderate negative market reaction.